Table 1 ADRs report according to European Commission Impact
From: Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
Patient’s report | Percentage reported |
|---|---|
Patients admitted in hospital | 0.3% - 5% |
Patient’s death reported | 3.5% |
Patient’s reported with ADR during their hospital stay | 1.9% -6% |